Aspen Pharmacare (OTCMKTS:APNHY) Shares Gap Up – Should You Buy?

Shares of Aspen Pharmacare (OTCMKTS:APNHYGet Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $7.24, but opened at $7.89. Aspen Pharmacare shares last traded at $7.89, with a volume of 552 shares.

Aspen Pharmacare Trading Up 9.0%

The stock has a fifty day moving average price of $6.58 and a 200-day moving average price of $6.05. The company has a quick ratio of 1.18, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

About Aspen Pharmacare

(Get Free Report)

Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.

Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.

Featured Articles

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.